Copeptin Serum Level in Liver Transplant Recipients

Completed

• Conditions: Liver Transplant; Liver Cirrhosis; Copeptin

• Registration Number: NCT03587623
• Lead Sponsor: Medical University of Warsaw

Brief Summary

The study aim is to measure perioperative copeptin concentration in blood of liver transplant recipients and to assess whether there is a correlation between its level and hemodynamic derangement.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2018-07-03
• Study Start: 2018-07-04
• Study First Submitted QC: 2018-07-13
• Study First Posted: 2018-07-16
• Primary Completion: 2020-01-31
• Study Completion: 2020-01-31
• Status Verified: 2020-08
• Last Update Submitted: 2020-08-15
• Last Update Posted: 2020-08-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 38

Inclusion Criteria

• Patient undergoing liver transplantation

Exclusion Criteria

• Serum creatinine > 1,5 mg/dl
• Retransplantation
• Patient refusal
• CRRT or dialysis preoperatively

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum Copeptin concentration	Baseline, intraoperatively, 1,3,7,21 day postoperatively

Trial Locations

Locations (1)

I Klinika Anestezjologii WUM; 🇵🇱 Warsaw, Mazovian Voivodeship, Poland